达标的管腔预处理对下肢动脉硬化闭塞症患者药物洗脱支架12个月一期通畅率的影响

刘翔宇; 邹雨池; 李鑫奕; 童强; 成军

doi:10.16016/j.2097-0927.202506034

您当前的位置：

首页 >

文章列表页 >

达标的管腔预处理对下肢动脉硬化闭塞症患者药物洗脱支架12个月一期通畅率的影响

临床医学 | 更新时间：2025-09-11

- 达标的管腔预处理对下肢动脉硬化闭塞症患者药物洗脱支架12个月一期通畅率的影响
- Effect of adequate vessel preparation on 12-month primary patency rate of drug-eluting stents in patients with lower extremity arteriosclerosis obliterans
- 陆军军医大学学报 2025年47卷第17期页码：2097-2105
- 作者机构：
  
  1.重庆医科大学附属第一医院血管外科，重庆
  2.陆军军医大学（第三军医大学）第二附属医院内分泌科，重庆
- 作者简介：
  
  成军，E-mail：cqdcj@163.com
- 基金信息：
  
  重庆市自然科学基金面上项目(CSTB2023NSCQ-MSX0376)
- DOI：10.16016/j.2097-0927.202506034
  中图分类号： R181.32;R543.5;R619
- 收稿日期：2025-06-11，
  
  修回日期：2025-08-01，
  
  录用日期：2025-08-08，
  
  纸质出版日期：2025-09-15
- 稿件说明：
移动端阅览
刘翔宇，邹雨池，李鑫奕，等.达标的管腔预处理对下肢动脉硬化闭塞症患者药物洗脱支架12个月一期通畅率的影响［J］.陆军军医大学学报，2025，47（17）：2097-2105.DOI：10.16016/j.2097-0927.202506034.

LIU X Y，ZOU Y C，LI X Y，et al.Effect of adequate vessel preparation on 12-month primary patency rate of drug-eluting stents in patients with lower extremity arteriosclerosis obliterans［J］.J Army Med Univ，2025，47（17）：2097-2105.DOI：10.16016/j.2097-0927.202506034.
刘翔宇，邹雨池，李鑫奕，等.达标的管腔预处理对下肢动脉硬化闭塞症患者药物洗脱支架12个月一期通畅率的影响［J］.陆军军医大学学报，2025，47（17）：2097-2105.DOI：10.16016/j.2097-0927.202506034. DOI：

LIU X Y，ZOU Y C，LI X Y，et al.Effect of adequate vessel preparation on 12-month primary patency rate of drug-eluting stents in patients with lower extremity arteriosclerosis obliterans［J］.J Army Med Univ，2025，47（17）：2097-2105.DOI：10.16016/j.2097-0927.202506034. DOI：

摘要

目的

探究达标的管腔预处理对下肢动脉硬化闭塞症（arteriosclerosis obliterans，ASO）患者药物洗脱支架（drug-eluting stents，DES）12个月一期通畅率的影响，并分析支架内再狭窄的独立预测因素。

方法

采用回顾性队列研究设计，纳入2022年4月至2024年4月在重庆医科大学附属第一医院血管外科接受DES治疗的141例ASO患者为研究对象。根据经皮腔内血管成形术（percutaneous transluminal angioplasty，PTA）后血管夹层分级（国家心肺血液研究所，C型及以上为严重夹层）及残余狭窄率（≥30%为重度狭窄），将不存在严重夹层和重度残余狭窄的患者纳入达标组（

=59），其余患者纳入未达标组（

=82）。采用彩色多普勒血管超声或血管造影评估DES 12个月一期通畅率，通畅的标准定义为血管超声收缩期峰值流速比≤2.4或血管造影狭窄

50%。采用Kaplan-Meier法比较组间DES通畅率及无临床驱动的靶病变血运重建（clinically driven target lesion revascularization，CD-TLR）率差异。采用多因素Logistic回归分析DES再狭窄的危险和保护因素，评估PTA后夹层和残余狭窄对DES再狭窄的风险贡献度。

结果

PTA后94.3%（133/141）的患肢出现血管夹层，其中42.1%（56/133）为严重夹层；44.0%（62/141）存在重度管腔残余狭窄。Kaplan-Meier生存分析显示，达标组DES 12个月一期通畅率显著高于未达标组（

=0.322，95%

：0.132~0.789，

=0.013），而无CD-TLR率组间差异无统计学意义（

=0.608，95%

：0.187~1.937，

=0.407）。多因素Logistic回归分析显示，达标的管腔预处理（

=0.228，95%

：0.069~0.747，

=0.015）和Rutherford分类2~3类（

=0.205，95%

：0.058~0.725，

=0.014）是DES再狭窄的独立保护因素。严重夹层与重度残余狭窄共存组的DES通畅率显著低于无并发症组（

0.001），且再狭窄风险达无并发症组的7.067倍（

0.001）。

结论

达标的管腔预处理可有效改善DES 12个月一期通畅率，并与Rutherford分类2~3类为支架内再狭窄的独立保护因素，术中应竭力避免同时出现严重夹层与重度残余狭窄。

Abstract

Objective‍　‍To investigate the impact of adequate lumen preparation on the 12-month primary patency rate of drug-eluting stents (DES) in patients with lower extremity arteriosclerosis obliterans （ASO） and to identify risk and protective factors for in-stent restenosis. Methods‍　‍A retrospective cohort study was conducted on 141 patients who underwent DES implantation for ASO at the Department of Vascular Surgery of the First Affiliated Hospital of Chongqing Medical University between April 2022 and April 2024. According to post-percutaneous transluminal angioplasty (PTA) dissection grade [severe dissection is defined as type C or higher based on National Heart

Lung

and Blood Institute (NHLBI) criteria

]

and residual stenosis rate (severe stenosis is defined as ≥30%)

the patients were categorized into an adequate preparation group (no severe dissection or severe residual stenosis;

=59) and an inadequate preparation group (

=82). DES primary patency at 12 months was assessed by color Doppler ultrasonography or angiography

defined as a peak systolic velocity ratio ≤2.4 on duplex ultrasound or angiographic stenosis

50%. Kaplan-Meier analysis was used to compare intergroup differences in DES patency rate and freedom from clinically driven target lesion revascularization (CD-TLR). Multivariate logistic regression analysis was employed to identify risk and protective factors for DES resteno

sis and to evaluate the risk contributions of post-PTA dissection and residual stenosis to DES restenosis. Results‍　‍Post-PTA

vascular dissection occurred in 94.3% (133/141) of treated limbs

among which 42.1% (56/133) were severe dissections

and severe residual stenosis was present in 44.0% (62/141) of limbs. Kaplan-Meier analysis revealed that the 12-month primary patency rate was significantly higher in the adequate preparation group than the inadequate group (

=0.322

95%

: 0.132~0.789

=0.013)

while no significant difference was found in the rate of freedom from CD-TLR (

=0.608

95%

: 0.187~1.937

=0.407). Multivariate logistic regression analysis identified adequate lumen preparation (

=0.228

95%

: 0.069~0.747

=0.015) and Rutherford category 2~3 (

=0.205

95%

: 0.058~0.725

=0.014) as independent protective factors against DES restenosis. The patency rate in the subgroup with coexisting severe dissection and residual stenosis was significantly lower than that in the uncomplicated group (55.6%

89.8%

0.001)

with a 7.067-fold increased risk of re-stenosis (95%

: 2.424~20.602

0.001). Conclusion‍　‍Adequate lumen preparation significantly improves the 12-month primary patency rate of DES. It

along with Rutherford category 2~3

serves as an independent protective factor against in-stent restenosis. Concurrent severe dissection and significant residual stenosis should be actively avoided during the procedure.

关键词

Keywords

references

SCULLY R E ， ARNAOUTAKIS D J ， DEBORD SMITH A ， et al . Estimated annual health care expenditures in individuals with peripheral arterial disease ［J］. J Vasc Surg ， 2018 ， 67 （ 2 ）： 558 - 567 . DOI： 10.1016/j.jvs.2017.06.102 http://dx.doi.org/10.1016/j.jvs.2017.06.102 .

MALYAR N ， FÜRSTENBERG T ， WELLMANN J ， et al . Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease： a nationwide population-based analysis ［J］. Eur Heart J ， 2013 ， 34 （ 34 ）： 2706 - 2714 . DOI： 10.1093/eurheartj/eht288 http://dx.doi.org/10.1093/eurheartj/eht288 .

GOLZAR J ， SOGA Y ， BABAEV A ， et al . Effectiveness and safety of a paclitaxel-eluting stent for superficial femoral artery lesions up to 190 mm： one-year outcomes of the single-arm IMPERIAL long lesion substudy of the eluvia drug-eluting stent ［J］. J Endovasc Ther ， 2020 ， 27 （ 2 ）： 296 - 303 . DOI： 10.1177/1526602820901723 http://dx.doi.org/10.1177/1526602820901723 .

MÜLLER-HÜLSBECK S ， KEIRSE K ， ZELLER T ， et al . Twelve-month results from the MAJESTIC trial of the eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease ［J］. J Endovasc Ther ， 2016 ， 23 （ 5 ）： 701 - 707 . DOI： 10.1177/1526602816650206 http://dx.doi.org/10.1177/1526602816650206 .

GOUËFFIC Y ， TORSELLO G ， ZELLER T ， et al . Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease： primary results of the EMINENT randomized trial ［J］. Circulation ， 2022 ， 146 （ 21 ）： 1564 - 1576 . DOI： 10.1161/CIRCULATIONAHA.122. 059606 http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059606 .

FUJIHARA M ， TAKAHARA M ， SASAKI S ， et al . Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease ［J］. J Endovasc Ther ， 2017 ， 24 （ 3 ）： 367 - 375 . DOI： 10.1177/1526602817698634 http://dx.doi.org/10.1177/1526602817698634 .

SAUCY F ， PROBST H ， TRUNFIO R . Vessel preparation is essential to optimize endovascular therapy of infrainguinal lesions ［J］. Front Cardiovasc Med ， 2020 ， 7 ： 558129 . DOI： 10.3389/fcvm.2020.558129 http://dx.doi.org/10.3389/fcvm.2020.558129 .

STONER M C ， CALLIGARO K D ， CHAER R A ， et al . Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease ［J］. J Vasc Surg ， 2016 ， 64 （ 1 ）： e1 - e21 . DOI： 10.1016/j.jvs.2016.03.420 http://dx.doi.org/10.1016/j.jvs.2016.03.420 .

ROGERS J H ， LASALA J M . Coronary artery dissection and perforation complicating percutaneous coronary intervention ［J］. J Invasive Cardiol ， 2004 ， 16 （ 9 ）： 493 - 499 .

MORI S ， TAKAHARA M ， NAKAMA T ， et al . Impact of calcification on clinical outcomes after drug-coated balloon angioplasty for superficial femoral artery disease： Assessment using the peripheral artery calcification scoring system ［J］. Catheter Cardiovasc Interv ， 2023 ， 101 （ 5 ）： 892 - 899 . DOI： 10.1002/ccd.30622 http://dx.doi.org/10.1002/ccd.30622 .

SCHLAGER O ， FRANCESCONI M ， HAUMER M ， et al . Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a “real-world” setting ［J］. J Endovasc Ther ， 2007 ， 14 （ 4 ）： 452 - 459 . DOI： 10.1177/152660280701400404 http://dx.doi.org/10.1177/152660280701400404 .

RUTHERFORD R B ， BECKER G J . Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease ［J］. Radiology ， 1991 ， 181 （ 1 ）： 277 - 281 . DOI： 10.1148/radiology.181.1.1887047 http://dx.doi.org/10.1148/radiology.181.1.1887047 .

TSUJIMURA T ， IIDA O ， TAKAHARA M ， et al . Clinical impact of intravascular ultrasound-guided fluoropolymer-based drug-eluting stent implantation for femoropopliteal lesions ［J］. JACC Cardiovasc Interv ， 2022 ， 15 （ 15 ）： 1569 - 1578 . DOI： 10.1016/j.jcin.2022.06.012 http://dx.doi.org/10.1016/j.jcin.2022.06.012 .

KOSKINAS K C ， CHATZIZISIS Y S ， ANTONIADIS A P ， et al . Role of endothelial shear stress in stent restenosis and thrombosis： pathophysiologic mechanisms and implications for clinical translation ［J］. J Am Coll Cardiol ， 2012 ， 59 （ 15 ）： 1337 - 1349 . DOI： 10.1016/j.jacc.2011.10.903 http://dx.doi.org/10.1016/j.jacc.2011.10.903 .

IIDA O ， FUJIHARA M ， KAWASAKI D ， et al . 24-month efficacy and safety results from Japanese patients in the IMPERIAL randomized study of the eluvia drug-eluting stent and the zilver PTX drug-coated stent ［J］. Cardiovasc Intervent Radiol ， 2021 ， 44 （ 9 ）： 1367 - 1374 . DOI： 10.1007/s00270-021-02901-6 http://dx.doi.org/10.1007/s00270-021-02901-6 .

RÄBER L ， JÜNI P ， LÖFFEL L ， et al . Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation ［J］. J Am Coll Cardiol ， 2010 ， 55 （ 12 ）： 1178 - 1188 . DOI： 10.1016/j.jacc.2009.11.052 http://dx.doi.org/10.1016/j.jacc.2009.11.052 .

BILDIRICI U ， AKTAS M ， DERVIS E ， et al . Mid-term outcomes of stent overlap in long total occluded lesions of superficial femoral artery ［J］. Med Sci Monit ， 2017 ， 23 ： 3130 - 3135 . DOI： 10.12659/msm.902413 http://dx.doi.org/10.12659/msm.902413 .

COUGHLAN J J ， AYTEKIN A ， KOCH T ， et al . Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap ［J］. Catheter Cardiovasc Interv ， 2022 ， 99 （ 3 ）： 541 - 551 . DOI： 10.1002/ccd.29944 http://dx.doi.org/10.1002/ccd.29944 .

CHEN X ， GAO X F ， KAN J ， et al . Overlapping drug-eluting stent is associated with increased definite stent thrombosis and revascularization： results from 15， 561 patients in the AUTHENTIC study ［J］. Cardiovasc Drugs Ther ， 2021 ， 35 （ 2 ）： 331 - 341 . DOI： 10.1007/s10557-020-07094-7 http://dx.doi.org/10.1007/s10557-020-07094-7 .

KIM Y G ， OH I Y ， KWON Y W ， et al . Mechanism of edge restenosis after drug-eluting stent implantation. Angulation at the edge and mechanical properties of the stent ［J］. Circ J ， 2013 ， 77 （ 12 ）： 2928 - 2935 . DOI： 10.1253/circj.cj-12-1259 http://dx.doi.org/10.1253/circj.cj-12-1259 .

YOON H J ， HUR S H . Optimization of stent deployment by intravascular ultrasound ［J］. Korean J Intern Med ， 2012 ， 27 （ 1 ）： 30 - 38 . DOI： 10.3904/kjim.2012.27.1.30 http://dx.doi.org/10.3904/kjim.2012.27.1.30 .

LANDMESSER U ， ALI Z A ， MAEHARA A ， et al . Optical coherence tomography predictors of clinical outcomes after stent implantation： the ILUMIEN IV trial ［J］. Eur Heart J ， 2024 ， 45 （ 43 ）： 4630 - 4643 . DOI： 10.1093/eurheartj/ehae521 http://dx.doi.org/10.1093/eurheartj/ehae521 .

SHIMADA T ， SHIMA Y ， MIURA K ， et al . Impact of guidewire route on severe dissection after balloon angioplasty for femoropopliteal chronic total occlusion lesions： an intravascular ultrasound analysis ［J］. Eur J Vasc Endovasc Surg ， 2021 ， 61 （ 5 ）： 830 - 836 . DOI： 10.1016/j.ejvs.2021.01.014 http://dx.doi.org/10.1016/j.ejvs.2021.01.014 .

TAN M ， URASAWA K ， KOSHIDA R ， et al . Comparison of angiographic dissection patterns caused by long vs short balloons during balloon angioplasty of chronic femoropopliteal occlusions ［J］. J Endovasc Ther ， 2018 ， 25 （ 2 ）： 192 - 200 . DOI： 10.1177/1526602818756610 http://dx.doi.org/10.1177/1526602818756610 .

ZORGER N ， MANKE C ， LENHART M ， et al . Peripheral arterial balloon angioplasty： effect of short versus long balloon inflation times on the morphologic results ［J］. J Vasc Interv Radiol ， 2002 ， 13 （ 4 ）： 355 - 359 . DOI： 10.1016/s1051-0443（07）61736-9 http://dx.doi.org/10.1016/s1051-0443（07）61736-9 .

HORIE K ， TANAKA A ， TAGURI M ， et al . Impact of prolonged inflation times during plain balloon angioplasty on angiographic dissection in femoropopliteal lesions ［J］. J Endovasc Ther ， 2018 ， 25 （ 6 ）： 683 - 691 . DOI： 10.1177/1526602818799733 http://dx.doi.org/10.1177/1526602818799733 .

SCHÖFTHALER C ， TROISI N ， TORSELLO G ， et al . Safety and effectiveness of the Phoenix atherectomy device for endovascular treatment of common femoral and popliteal arteries： Results of the EN-MOBILE trial ［J］. Vasc Med ， 2024 ， 29 （ 4 ）： 405 - 415 . DOI： 10.1177/1358863X241231943 http://dx.doi.org/10.1177/1358863X241231943 .

TSUKAGOSHI J ， SHIMODA T ， YOKOYAMA Y ， et al . The mid-term effect of intravascular ultrasound on endovascular interventions for lower extremity peripheral arterial disease： a systematic review and meta-analysis ［J］. J Vasc Surg ， 2024 ， 79 （ 4 ）： 963 - 972.e11 . DOI： 10.1016/j.jvs.2023.08.128 http://dx.doi.org/10.1016/j.jvs.2023.08.128 .

XU R ， ZHAO Q ， WANG T ， et al . Optical coherence tomography in cerebrovascular disease： open up new horizons ［J］. Transl Stroke Res ， 2023 ， 14 （ 2 ）： 137 - 145 . DOI： 10.1007/s12975-022-01023-6 http://dx.doi.org/10.1007/s12975-022-01023-6 .

邹雨池，童强，王学虎，等 . 下肢动脉硬化闭塞症患者经皮穿刺血管成形术后12个月内再狭窄风险预测模型建立［J］. 陆军军医大学学报， 2023 ， 45 （ 7 ）： 705 - 714 . DOI： 10.16016/j.2097-0927.202210141 http://dx.doi.org/10.16016/j.2097-0927.202210141 .

ZOU Y C ， TONG Q ， WANG X H ， et al . Development and validation of a nomogram for predicting restenosis in 12 months after percutaneous transluminal angioplasty of arteriosclerosis obliterans ［J］. J Army Med Univ ， 2023 ， 45 （ 7 ）： 705 - 714 . DOI： 10.16016/j.2097-0927.202210141 http://dx.doi.org/10.16016/j.2097-0927.202210141 .

ROOKE T W ， HIRSCH A T ， MISRA S ， et al . 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease （updating the 2005 guideline）： a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ［J］. J Am Coll Cardiol ， 2011 ， 58 （ 19 ）： 2020 - 2045 . DOI： 10.1016/j.jacc.2011.08.023 http://dx.doi.org/10.1016/j.jacc.2011.08.023 .

ILO A ， ROMSI P ， MÄKELÄ J . Infrared thermography and vascular disorders in diabetic feet ［J］. J Diabetes Sci Technol ， 2020 ， 14 （ 1 ）： 28 - 36 . DOI： 10.1177/1932296819871270 http://dx.doi.org/10.1177/1932296819871270 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

下肢动脉硬化闭塞症患者经皮穿刺血管成形术后12个月内再狭窄风险预测模型建立